Metabolic derangements with olanzapine and risperidone in schizophrenia spectrum and other psychotic disorders: A prospective 24-week study

Downloads

Published

2021-09-08

DOI:

https://doi.org/10.54169/indjofclinicalpsychiatry.v1i01.22

Keywords:

.

Dimensions Badge

Issue

Vol. 1 No. 1 (2021): Indian Journal of Clinical Psychiatry

Section

Articles

License

Copyright (c) 2021 Indian Journal of Clinical Psychiatry

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors

  • Praveen Rikhari Postgraduate resident (3rd year), Department of Psychiatry, S N Medical College, Agra
  • Ashutosh Kumar Assistant Professor and Head, Department of Psychiatry, S N Medical College, Agra

Abstract

Metabolic derangements are common with antipsychotic medications leading to increased morbidity and mortality due to diabetes mellitus, stroke, and cardiovascular events in schizophrenia spectrum and other psychotic disorders as these require long term treatment.

How to Cite

Rikhari, P., & Kumar, A. (2021). Metabolic derangements with olanzapine and risperidone in schizophrenia spectrum and other psychotic disorders: A prospective 24-week study. Indian Journal of Clinical Psychiatry, 1(1). https://doi.org/10.54169/indjofclinicalpsychiatry.v1i01.22

Downloads

Download data is not yet available.